Autoimmune/inflammatory syndrome induced by adjuvants

From WikiMD's Medical Encyclopedia

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a proposed condition that encompasses a variety of autoimmune and inflammatory responses triggered by adjuvants. Adjuvants are substances that are added to vaccines and other medications to enhance the body's immune response to an antigen.

Overview[edit]

The concept of Autoimmune/inflammatory syndrome induced by adjuvants was introduced by Dr. Yehuda Shoenfeld in 2011. The syndrome suggests that certain individuals may develop autoimmune or inflammatory conditions following exposure to adjuvants. These conditions can include a range of symptoms and diseases, such as chronic fatigue, muscle pain, and autoimmune diseases like lupus and rheumatoid arthritis.

Adjuvants[edit]

Adjuvants are used in vaccines to improve the immune response. Common adjuvants include aluminum salts, oil emulsions, and squalene. While adjuvants are generally considered safe, the ASIA hypothesis suggests that they may trigger adverse immune responses in susceptible individuals.

Symptoms[edit]

The symptoms of ASIA can vary widely but often include:

  • Chronic fatigue
  • Muscle and joint pain
  • Cognitive difficulties
  • Skin rashes
  • Autoimmune diseases such as lupus and rheumatoid arthritis

Diagnosis[edit]

Diagnosing ASIA can be challenging due to the broad range of symptoms and the lack of specific diagnostic tests. Diagnosis is often based on clinical evaluation and the exclusion of other conditions. A history of exposure to adjuvants and the temporal relationship between exposure and symptom onset are considered in the diagnostic process.

Controversy[edit]

The existence of ASIA as a distinct syndrome is controversial. Critics argue that the evidence supporting ASIA is limited and that the symptoms attributed to ASIA can be explained by other well-established medical conditions. Proponents of ASIA argue that more research is needed to understand the potential link between adjuvants and autoimmune responses.

Related pages[edit]



Medical Disclaimer: The information on WikiMD is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter this site.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.